Eargo 7 vs Otofonix Encore

The Eargo 7 is a premium-priced OTC hearing aid at $2,550, earning a B grade with a SoundScore of 3.4/5 in our lab testing. This invisible-in-ear device ranks #38 of 65 OTC hearing aids tested, placing it in the top 57% of its category. In our testing, the Eargo 7 demonstrates solid speech clarity in quiet environments, scoring 3.1/5—0.33 points above the OTC category average. Own-voice comfort also performs above average at 2.9/5, which is +0.39 points versus typical OTC devices, though only mixed in absolute terms. However, speech understanding in noisy situations is a weakness, scoring just 1.0/5, which falls 0.44 points below the category average. The most notable limitation is music streaming, which scored 0.0/5 in our lab measurements—1.92 points below the OTC average. Feedback handling is solid at 3.8/5 in absolute terms, though this is 0.74 points below the category average of 4.54/5. The Eargo 7 may appeal to users prioritizing a completely invisible design who primarily need help with speech in quieter settings. However, given its premium price point, consumers should note that several lower-priced alternatives in our database achieved higher overall sound scores. Those who frequently stream music or struggle in noisy environments may want to explore other options.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.